Guardian Pharmacy Services, Inc.
For the period ended Sep 30, 2025. Filed Nov 10, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 10, 2025
GRDN$47.02+10.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (In thousands, except share and per share amounts) | 2024 | 2025 | 2024 | 2025 |
| Revenues | $314,393 | $377,427 | $889,840 | $1,051,069 |
| Cost of goods sold | 253,515 | 302,706 | 712,573 | 843,853 |
| Gross profit | 60,878 | 74,721 | 177,267 | 207,216 |
| Selling, general, and administrative expenses | 165,491 | 58,367 | 256,942 | 165,277 |
| Operating income (loss) | (104,613) | 16,354 | (79,675) | 41,939 |
| Other expenses (income): | ||||
| Interest expense | 1,026 | 160 | 2,857 | 502 |
| Other expense (income), net | 2 | (437) | 166 | (887) |
| Total other expenses (income) | 1,028 | (277) | 3,023 | (385) |
| Income (loss) before income taxes | (105,641) | 16,631 | (82,698) | 42,324 |
| Provision for income taxes | 176 | 7,038 | 176 | 14,631 |
| Net income (loss) | (105,817) | 9,593 | (82,874) | 27,693 |
| Less net income attributable to Guardian Pharmacy, LLC prior to the Corporate Reorganization | 9,350 | — | 22,760 | — |
| Less net income (loss) attributable to non-controlling interests | 6,823 | (225) | 16,356 | (603) |
| Net income (loss) attributable to Guardian Pharmacy Services, Inc. | $(121,990) | $9,818 | $(121,990) | $28,296 |
| Basic | $(2.00) | $0.16 | $(2.00) | $0.46 |
| Diluted | $(2.00) | $0.15 | $(2.00) | $0.45 |
| Weighted-average Class A and Class B common shares outstanding | ||||
| Basic | 61,143,311 | 62,124,010 | 61,143,311 | 62,071,370 |
| Diluted | 61,143,311 | 63,432,468 | 61,143,311 | 63,179,784 |
| 1 | See Note 6 Basic and Diluted Net Income Per Share for the number of shares used in the computation of net income per share of Class A and Class B common stock and the basis for the computation of net income per share. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.